Adjunctive topical mesenchymal stem cell-derived secretome-enriched biological dressings in pediatric complex wounds: a retrospective case series
Frontiers in Medicine · 19.05.2026 · 13
DOI: 10.3389/fmed.2026.1795253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 19.05.2026. Verfasst von José Ramón García-Lira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Dermatology, Federico Gómez Children's Hospital, Mexico City, Mexico. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Mesenchymal stem cell (MSC)-derived secretome, including extracellular vesicles (EVs), has emerged as a potential cell-free regenerative approach due to its immunomodulatory and tissue repair-associated properties. While topical applications have been explored in adult dermatologic settings, clinical evidence in pediatric patients with complex cutaneous wounds remains scarce.
Methods
A retrospective observational case series was conducted at a tertiary referral pediatric hospital. Medical records and photographic documentation of six pediatric patients with complex cutaneous wounds treated with topical biological dressings containing MSC-derived secretome enriched in EVs were reviewed between January 2020 and January 2024. All patients received standard-of-care management in addition to adjunctive application of the biological dressings. Clinical evolution and treatment tolerability were assessed descriptively.
Results
Progressive re-epithelialization and clinical improvement were observed across all cases based on clinical and photographic assessment. Time to complete re-epithelialization ranged from 6 to 14 days across heterogeneous wound etiologies. Estimated wound reduction ranged from approximately 85 to >90% at defined time points. No treatment-related adverse events were documented during follow-up.
Conclusion
In this retrospective case series, progressive re-epithelialization was documented during follow-up in pediatric patients with complex cutaneous wounds receiving adjunctive topical MSC-derived secretome-enriched biological dressings alongside standard care. However, given the observational design, small sample size, heterogeneous diagnoses, and absence of a control group, these findings should be interpreted as descriptive and hypothesis-generating. Prospective, controlled studies are needed to better define the therapeutic role and safety profile of these interventions in pediatric regenerative dermatology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Dermatology, Federico Gómez Children's Hospital, Mexico City, Mexico.
- Intensive Care Unit, Federico Gómez Children's Hospital, Mexico City, Mexico.
Zitieren
APA
García-Lira, J. R., Valencia-Herrera, A. M., Toledo-Bahena, M. E., Mena-Cedillos, C. A., & Chávez-López, A. (2026). Adjunctive topical mesenchymal stem cell-derived secretome-enriched biological dressings in pediatric complex wounds: a retrospective case series. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1795253
Vancouver
García-Lira JR, Valencia-Herrera AM, Toledo-Bahena ME, Mena-Cedillos CA, Chávez-López A. Adjunctive topical mesenchymal stem cell-derived secretome-enriched biological dressings in pediatric complex wounds: a retrospective case series. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1795253
BibTeX
@article{GarcaLira2026,
author = {García-Lira, José Ramón and Valencia-Herrera, Adriana Maria and Toledo-Bahena, Mirna Eréndira and Mena-Cedillos, Carlos Alfredo and Chávez-López, Adrián},
title = {Adjunctive topical mesenchymal stem cell-derived secretome-enriched biological dressings in pediatric complex wounds: a retrospective case series},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1795253}
}
EUVIMED